Application of osteopontin in preparation or screening of diagnostic reagents for acute-on-chronic liver failure
A technology for acute liver failure and osteopontin, which is applied in the fields of biomedicine and disease diagnosis, and can solve problems such as limitations of timely diagnosis, invasiveness, complex and time-consuming diagnostic methods, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0057] 1. Experimental method
[0058] Peripheral blood samples were collected from 70 patients with confirmed acute-on-chronic liver failure (ACLF+), 67 patients with decompensated liver cirrhosis (ACLF-), 50 patients with hepatocellular carcinoma (HCC), and 30 normal people (Health). A blood sample was collected in a coagulation tube with a volume of about 5ml, centrifuged at 5000rpm for 10min, and the upper clarified serum was absorbed. The concentrations of osteopontin, M30, and M65 in serum were detected by ELISA kits (Osteopontin enzyme-linked immunosorbent assay kit was purchased from R&D Systems, article number: DOST00; M30, M65 enzyme-linked immunosorbent assay kit was purchased from VLVbio company, article number: nr.10011 and nr.10040), MELD, total bilirubin and creatinine concentrations were obtained from patient history data. GraphPad Prism 6.0 software was used to draw the ROC curve, Mann-Whitney test was used for comparison between groups, and Spearman correlat...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com